As the COVID-19 pandemic has highlighted the critical role of drug safety monitoring, do join expert pharmacovigilance trainers for this 2.5-day workshop, jointly organised with the World Health Organisation (WHO), the Uppsala Monitoring Centre (UMC), Health Sciences Authority (HSA), and CoRE, as part of a continuation of efforts to enhance capabilities of pharmacovigilance in South East Asia, as well as discuss the latest trends that will improve the effectiveness of drug safety monitoring.
Click here to register!
To view full programme in pdf, click here.
